| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5841516 | Life Sciences | 2016 | 5 Pages |
Abstract
This study provided pharmacological evidence that tapentadol inhibits stimulated CGRP release from the rat brainstem in vitro through a mechanism involving an increase in 5-HT levels in the system and the subsequent activation of 5-HT3 receptors.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maria Cristina Greco, Pierluigi Navarra, Giuseppe Tringali,
